Future Growth of Kidney Stone Market by Top 10 Players Till 2023 | Electro Medical Systems S.A., DirexGroup, Boston Scientific Corp and More

The Global Kidney Stone Market is anticipated to expand at a 4% CAGR from 2017 to 2022 (forecast period), according to the latest report by Market Research Future (MRFR). The emergence of minimally invasive procedures to remove kidney stones coupled with its preference by patients can drive its demand over the forecast period. Malnutrition and rising cases of urolithiasis in adults are other factors which can impact the market. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), nearly one million cases are registered in the U.S. This factor coupled with improvements in imaging techniques can bolster the market growth in the coming years.

Market Research Future (MRFR) report states that the global kidney stones market is set to cross the valuation of USD 3,000.0 Million by 2022. The market will progress at an impressive growth rate during the forecast period (2017-2022). Kidney stone market has observed a stable growth rate over the past few years, with the trend set to continue further on account of increasing prevalence and recurrence rate of kidney stones globally. Other protuberant factors associated with the market growth include growing demand for minimally invasive procedures and the burgeoning population along with poor nutrition.

Get Exclusive Sample Report PDF @ https://www.marketresearchfuture.com/sample_request/1745

Global Kidney Stone Market – Competitive Dashboard

The key players in this market are Boston Scientific Corp., C.R. Bard Inc., Convergent Laser Technologies, Cook Medical Inc., DirexGroup, Dornier MedTech GmbH, E.M.S. Electro Medical Systems S.A., Elmed Electronics & Medical Industry & Trade Inc., Medispec Ltd., Olympus Corp., Richard Wolf GmbH, Siemens Ltd., STORZ MEDICAL AG, Stryker Corp and others.

Global Kidney Stone Market – Segmental Analysis

The global kidney stone market is segmented based on type, treatment type, and diagnosis.

The market, by type, is sub-segmented into calcium stones, uric acid, struvite kidney stones, and cystine stones. The revenue generated because of the treatment of calcium stones was the highest with a substantial market share of around 52.4% in 2015. The market is further is expected to reach the valuation of USD 1,561.7 million by 2022.

By treatment type, the market is segmented based on medications, Extracorporeal Shock Wave Lithotripsy (ESWL), Ureteroscopy (URS), and Percutaneous Nephrolithotomy (PCNL). Ureteroscopy helps diagnose and treat medical problems of the urinary tract. It enables the urologist to remove the stone in the ureter without the need for open surgery. It can be used in patients who are morbidly obese, pregnant or have blood clotting disorder. Thus, on the basis of these advantages, the segment of ureteroscopy dominates the market and is expected to reach USD 989.9 million by 2022.

The diagnosis segment is sub-segmented into ultrasound, Intravenous Pyelography (IVP) or intravenous urogram, CT scan, and X-ray. Diagnosis with ultrasound is quick and reliable, as it does not involve exposure to radiation. On account of this appealing feature, the ultrasound segment accounted for the largest market share and had claimed 38.6% of the market share. The segment is further anticipated to reach USD 1101.6 million by 2022.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/kidney-stones-market-1745

Regional Outlook

The Global Kidney Stone Market is split into the regions of North America, Europe, Asia Pacific, and the Middle East and Africa.

Among all regions, North America owned the largest market share of 43.9% in 2015 due to the high prevalence of kidney stones in this region. The flourishing healthcare sector along with technological advancements is predicted to trigger the regional market growth. The Americas, overall, is expected to reach USD 1243.3 million by 2022.

On the other hand, Europe accounts for the second largest market globally and also the fastest growing market on account of medical advances and the availability of minimally invasive treatments.

Asia Pacific managed to secure the third position among all regions with the third largest market share in 2015. In the region, China claimed the largest market share of 30.1% and is forecasted to reach USD 155.9 million by 2022. The region also observes rising consumerism and unhealthy lifestyle that gives birth to kidney stone incidences. Thus, the market can surge ahead without any major challenges in the region.

Lastly, the Middle East and Africa accounted for the least market share owing to the poor economic growth rate. On the other hand, the market is predicted to experience steady growth in the coming years on the back of improving healthcare facilities and infrastructure coupled with the government support.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.